Matthias Jung

Dr. Matthias Jung

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
PAPhilipp Ackermann
Philipp Ackermann
SHSusann Hetz
Susann Hetz
JDJulia Dieckow
Julia Dieckow
MSMartin Schicht
Martin Schicht
ARAnja Richter
Anja Richter
Friedrich  PaulsenFriedrich Paulsen
Friedrich Paulsen
Purpose: Aqueous tear deficiency due to lacrimal gland insufficiency is one of the major causes of dry eye disease. In severe cases, such as Sjogren's syndrome, Stevens-Johnson syndrome, or ocular cicatricial pemphigoid, therapy with artificial tears is often insufficient to relieve severe discomfort, prevent progressive ocular surface disease, or enable visual rehabilitation by corneal transplantation. Cell or organ generation from stem cells, resulting in tear-like secretion, presents an option as a suitable alternative treatment. To obtain deeper insights into lacrimal gland stem cells we analyzed murine lacrimal glands for markers of pluripotency, self-renewal, and differentiation. Methods: A special, patented technique with mechanical and enzymatic digestion was used to generate high numbers of cells in vitro from murine lacrimal glands. These presumptive “murine lacrimal gland stem cells” (“mLGSCs”) can be propagated as monolayer cultures over multiple passages. By means of RT-PCR, Western blot, and immunohistochemistry, markers of pluripotency and differentiation were demonstrated. Hanging drop culture was used to build organoid bodies from mLGSCs to investigate their spontaneous differentiation in three-dimensional culture with histology, immunohistochemistry, and transmission electron microscopy methods. Results: Isolated mLGSCs were cultured over more than 65 passages. Murine lacrimal gland stem cells expressed markers of pluripotency such as Nanog, Sox2, Kruppel-like factor 4 (Klf4), as well as early-lineage markers of all three germ layers. Three-dimensional culture of these cells revealed their ability to differentiate into various cell types. Conclusions: Our results suggest that mLGSCs were isolated and cultured successfully. These cells have the ability to differentiate into all three germ layers. The results provide further insights into lacrimal gland stem cell physiology for engineering of a lacrimal gland construct to treat severe cases of tear deficiency in the future.

1 February 2013 in Cellular Reprogramming
Verified
Journal Article
Closed access
SFSabine Foja
Sabine Foja
Matthias JungMatthias Jung
Matthias Jung
BHBernadette Harwardt
Bernadette Harwardt
DRDagmar Riemann
Dagmar Riemann
OPOliver Pelz-Ackermann
Oliver Pelz-Ackermann
ISInsa S. Schroeder
Insa S. Schroeder
Pluripotency is characterized by specific transcription factors such as OCT4, NANOG, and SOX2, but also by pluripotency-associated microRNAs (miRs). Somatic cells can be reprogrammed by forced expression of these factors leading to induced pluripotent stem cells (iPSCs) with characteristics similar to embryonic stem cells (ESCs). However, current reprogramming strategies are commonly based on viral delivery of the pluripotency-associated factors, which affects the integrity of the genome and impedes the use of such cells in any clinical application. In an effort to establish nonviral, nonintegrating reprogramming strategies, we examined the influence of hypoxia on the expression of pluripotency-associated factors and the ESC-specific miR-302 cluster in primary and immortalized mesenchymal stromal cells (MSCs). The combination of hypoxia and fibroblast growth factor 2 (FGF2) treatments led to the induction of OCT4 and NANOG in an immortalized cell line L87 and primary MSCs, accompanied with increased doubling rates and decreased senescence. Most importantly, the endogenous ECS-specific cluster miR-302 was induced upon hypoxic culture and FGF2 supplementation. Hypoxia also improved reprogramming of MSCs via episomal expression of pluripotency factors. Thus, our data illustrate that hypoxia in combination with FGF2 supplementation efficiently facilitates reprogramming of MSCs.

1 August 2019 in Cellular Reprogramming
Verified
Journal Article
Closed access
JJJuliane-Susanne Jung
Juliane-Susanne Jung
CVChristin Volk
Christin Volk
CMChristina Marga
Christina Marga
ASAlexander Navarrete Santos
Alexander Navarrete Santos
Matthias JungMatthias Jung
Matthias Jung
ASAnne Navarrete Santos
Anne Navarrete Santos
Stromal mesenchymal stem cells (MSCs) have the capability to self-renew and can differentiate into multiple cell types of the mesoderm germ layer, but their properties are affected by molecular aging mechanisms. MSCs can be obtained from adipose tissue termed as adipose-derived stem/stromal cells (ASCs) representing a promising tool for studying age-related diseases in detail. ASCs from young (16 weeks) and old (>108 weeks) rabbits were successfully isolated and propagated. ASCs showed the typical morphology and stained positive for CD105, Vimentin, Collagenase 1A, and negative for CD14, CD90, and CD73, demonstrating their mesenchymal origin. ASCs expressed MSC markers, including MYC, KLF4, CHD1, REST, and KAT6A, whereas pluripotency-related genes, such as NANOG, OCT4, and SOX2, were not expressed. Aged ASCs showed altered protein and mRNA levels of APOE, ATG7, FGF2, PTEN, and SIRT1. Adipogenic differentiation of old visceral ASCs was significantly decreased compared with young visceral ASCs. We successfully established rabbit ASC cultures representing an in vitro model for the analysis of stem cell aging mechanisms. ASCs, obtained from old female rabbits, showed age- and source-specific alteration due to aging of the donor. Stem cell plasticity was altered with age as shown by reduced adipogenic differentiation capacity.

26 October 2017 in ACS Infectious Diseases
Verified
Journal Article
Closed access
DHDenise Hübner
Denise Hübner
KJKristin Jahn
Kristin Jahn
SPSandra Pinkert
Sandra Pinkert
JBJanik Böhnke
Janik Böhnke
Matthias JungMatthias Jung
Matthias Jung
CCClaudia Claus
Claudia Claus

5 July 2016 in ACS Nano
Verified
Journal Article
Closed access
URUta Reibetanz
Uta Reibetanz
DHDenise Hübner
Denise Hübner
Matthias JungMatthias Jung
Matthias Jung
ULUwe Gerd Liebert
Uwe Gerd Liebert
CCClaudia Claus
Claudia Claus

16 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Veronika WeberVeronika Weber
Veronika Weber
Heidi OlzschaHeidi Olzscha
Heidi Olzscha
TLTimo Längrich
Timo Längrich
CHCarla Hartmann
Carla Hartmann
Matthias JungMatthias Jung
Matthias Jung
KBKaya Bork
Kaya Bork
The function of the human blood–brain barrier (BBB), consisting mainly of the basement membrane and microvascular endothelial cells, is to protect the brain and regulate its metabolism. Dysfunction of the BBB can lead to increased permeability, which can be linked with several pathologies, including meningitis, sepsis, and postoperative delirium. Advanced glycation end products (AGE) are non-enzymatic, posttranslational modifications of proteins, which can affect their function. Increased AGE levels are strongly associated with ageing and degenerative diseases including diabetes. Several studies demonstrated that the formation of AGE interfere with the function of the BBB and may change its permeability for soluble compounds. However, it is still unclear whether AGE can facilitate microbial traversal through the BBB and how small compounds including anesthetics modulate this process. Therefore, we developed a cellular model, which allows for the convenient testing of different factors and compounds with a direct correlation to bacterial traversal through the BBB. Our results demonstrate that both glycation and anesthetics interfere with the function of the BBB and promote microbial traversal. Importantly, we also show that the essential nutrient and antioxidant ascorbic acid, commonly known as vitamin C, can reduce the microbial traversal through the BBB and partly reverse the effects of AGE.